Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Costing and Resource Utilization Analysis of Stage IV Gastric Cancer Patient Care
FY 2015-16
Summary
Gastric cancer is one of the most common cancers in the world and one of the leading causes of cancer deaths worldwide. In North America, gastric cancer is the third leading gastrointestinal cancer with the majority of patients treated for primary gastric cancer presenting with metastatic disease at the time of diagnosis. Even those treated with surgery for potential cure have medical courses complicated by high recurrence rates. Despite the high lethal potential of gastric cancer and a propensity for significant morbidity, there lacks evidence to guide therapeutic clinical decision making in patients with advanced disease. Current therapies for advanced gastric cancer include surgery, chemotherapy, radiotherapy, therapeutic endoscopy, or any combination of these modalities. While many modes of treatment are available, much variation exists in the therapeutic strategies utilized. This research project therefore aims to evaluate cost and analyze resource utilization for the care provided to patients with advanced gastric cancer to identify whether cost is a predictor of therapy provided. Once completed and compared with patient treatment outcomes, we hope for evidence-based, cost-effective, quality and safe gastric cancer patient care.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
350193
Name
Jeong Yunni
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Costing and Resource Utilization Analysis of Stage IV Gastric Cancer Patient Care
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Care; Costing; Gastric; Patient; Resource; Utilization
Abstract
Gastric cancer is one of the most common cancers in the world and one of the leading causes of cancer deaths worldwide. In North America, gastric cancer is the third leading gastrointestinal cancer with the majority of patients treated for primary gastric cancer presenting with metastatic disease at the time of diagnosis. Even those treated with surgery for potential cure have medical courses complicated by high recurrence rates. Despite the high lethal potential of gastric cancer and a propensity for significant morbidity, there lacks evidence to guide therapeutic clinical decision making in patients with advanced disease. Current therapies for advanced gastric cancer include surgery, chemotherapy, radiotherapy, therapeutic endoscopy, or any combination of these modalities. While many modes of treatment are available, much variation exists in the therapeutic strategies utilized. This research project therefore aims to evaluate cost and analyze resource utilization for the care provided to patients with advanced gastric cancer to identify whether cost is a predictor of therapy provided. Once completed and compared with patient treatment outcomes, we hope for evidence-based, cost-effective, quality and safe gastric cancer patient care.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jeong, Yunni
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~